Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Microbiology 151 (2005), 2087-2095; DOI  10.1099/mic.0.27938-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burguière, A.
Right arrow Articles by Besra, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burguière, A.
Right arrow Articles by Besra, G. S.
Agricola
Right arrow Articles by Burguière, A.
Right arrow Articles by Besra, G. S.
Microbiology 151 (2005), 2087-2095; DOI  10.1099/mic.0.27938-0
© 2005 Society for General Microbiology

Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole

Adeline Burguière1, Paul G. Hitchen2, Lynn G. Dover1, Anne Dell2 and Gurdyal S. Besra1

1 School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
2 Department of Biological Sciences, Imperial College, London, SW7 2AZ, UK

Correspondence
Gurdyal S. Besra
g.besra{at}bham.ac.uk

The azole antifungal drugs econazole and clotrimazole are known cytochrome P450 enzyme inhibitors. This study shows that these drugs are potent inhibitors of mycobacterial growth and are more effective against Mycobacterium smegmatis than isoniazid and ethionamide, two established anti-mycobacterial drugs. Several non-tuberculous mycobacteria, including the pathogenic members of the Mycobacterium avium–intracellulare complex (MAC) and the fast-growing saprophytic organism M. smegmatis, produce an array of serovar-specific (ss) and non-serovar-specific (ns) glycopeptidolipids (GPLs). GPL biosynthesis has been investigated for several years but has still not been fully elucidated. The authors demonstrate here that econazole and clotrimazole inhibit GPL biosynthesis in M. smegmatis. In particular, clotrimazole inhibits all four types of nsGPLs found in M. smegmatis, suggesting an early and common target within their biosynthetic pathway. Altogether, the data suggest that an azole-specific target, most likely a cytochrome P450, may be involved in the hydroxylation of the N-acyl chain in GPL biosynthesis. Azole antifungal drugs and potential derivatives could represent an interesting new range of anti-mycobacterial drugs, especially against opportunistic human pathogens including MAC, M. scrofulaceum, M. peregrinum, M. chelonae and M. abscessus.

Abbreviations: CAD-ES-MS/MS, collision-activated dissociation electrospray mass spectrometry–mass spectrometry; dGPL, de-O-acylated GPL; 6-dTal, 6-deoxytalose; EMB, ethambutol; ETH, ethionamide; GPL, glycopeptidolipid; INH, isoniazid; LOS, lipooligosaccharide; MAC, Mycobacterium avium–intracellulare complex; nsGPL, non-serovar-specific-GPL; PGL, phenolic glycolipid; Rha, rhamnose; ssGPL, serovar-specific-GPL




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
K. J. McLean, P. Carroll, D. G. Lewis, A. J. Dunford, H. E. Seward, R. Neeli, M. R. Cheesman, L. Marsollier, P. Douglas, W. E. Smith, et al.
Characterization of Active Site Structure in CYP121: A CYTOCHROME P450 ESSENTIAL FOR VIABILITY OF MYCOBACTERIUM TUBERCULOSIS H37Rv
J. Biol. Chem., November 28, 2008; 283(48): 33406 - 33416.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
J. S Schorey and L. Sweet
The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis
Glycobiology, November 1, 2008; 18(11): 832 - 841.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
V. Bhowruth, A. K. Brown, and G. S. Besra
Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636
Microbiology, July 1, 2008; 154(7): 1866 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. P. Pietila, P. K. Vohra, B. Sanyal, N. L. Wengenack, S. Raghavakaimal, and C. F. Thomas Jr.
Cloning and Characterization of CYP51 from Mycobacterium avium
Am. J. Respir. Cell Mol. Biol., August 1, 2006; 35(2): 236 - 242.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 Society for General Microbiology.